Skip to main content

Not investment advice.Read full disclaimer

RVLP: RVL Pharmaceuticals plc Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

2thpctl

Volume

2.62×avg

Market Cap

3.14MUSD

P/E Ratio

-0.0TTM

Div Yield

-ann

Continue with finqOS

Explore RVL Pharmaceuticals plc's financials

Income statements, balance sheets, and cash flows - annual and quarterly, going back 20+ years.

Start Free Trial→Sign In

14-day free trial · No credit card required

RVL Pharmaceuticals plc

RVLPNASDAQ·USD·Closed

RVL Pharmaceuticals plc

RVLPNASDAQ·USD·Closed

$0.03

−32.05%

$0.03

−$0.01 (32.05%)

52W Range

2thpctl

Volume

2.62×avg

Mkt Cap

3.14MUSD

P/E

-0.0TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings